New York · 2025 Regular Session · Bill
S 1817: Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 1817 is a bill introduced in the New York Senate on January 14, 2025. According to its official title, it concerns: Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment. Primary sponsor: Nathalia Fernández (Democratic). It lists 3 additional sponsors. Most recent recorded action (April 29, 2026): REPORTED AND COMMITTED TO FINANCE.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction.
Sponsors
Sponsors by party (alphabetical): Democratic 1 · Republican/Conservative 3
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Nathalia Fernández | Primary sponsor | Democratic | Senate | 34 |
| Jake Ashby | Co-sponsor | Republican/Conservative | Senate | 43 |
| Mario Mattera | Co-sponsor | Republican/Conservative | Senate | 2 |
| Steve Rhoads | Co-sponsor | Republican/Conservative | Senate | 5 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REPORTED AND COMMITTED TO FINANCE
- REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS
- REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS